China might be the frontrunners when it comes to medical advances, but questions surrounding their ethical lapses, hinders their successes.
Can China Up Their Bioethics Game?
Can China Up Their Bioethics Game?China might be the frontrunners when it comes to medical advances, but questions surrounding their ethical lapses, hinders their successes.
Cancer Genomics 101: 2018 Edition
Cancer Genomics 101: 2018 EditionFree download: This guide is intended to help you understand how cancers can develop in the body and what forms they can take, as well as taking you through the medical processes of diagnosis and treatment.
Has Precision Oncology Been Over-Promised?
Has Precision Oncology Been Over-Promised?A debate at AACR raised the question of whether or not the idea of precision therapies targeting a patient’s cancer genome has been oversold,
Why Are Some E.Coli Deadly While Others Live Peacefully Within Our Bodies?
Why Are Some E.Coli Deadly While Others Live Peacefully Within Our Bodies?E. coli bacteria are the frequent culprits behind outbreaks of food-borne illnesses. But not all strains are harmful; some are even helpful.
Freenome Partner With Biognosys on Early Cancer Detection
Freenome Partner With Biognosys on Early Cancer DetectionAI genomics company Freenome has announced a partnership with proteomics company Biognosys, to enhance its broad-signal approach to early-cancer detection and precision oncology.
Novartis’ entry into the digital technology market intensifies with the recent launch of its mobile-phone based app to help collect data from eye disease studies.
A debate at AACR raised the question of whether or not the idea of precision therapies targeting a patient’s cancer genome has been oversold,
E. coli bacteria are the frequent culprits behind outbreaks of food-borne illnesses. But not all strains are harmful; some are even helpful.
AI genomics company Freenome has announced a partnership with proteomics company Biognosys, to enhance its broad-signal approach to early-cancer detection and precision oncology.
Less than half the patients diagnosed with cancer respond favourably to chemotherapy. Now, a new method for testing how patients will respond to various drugs could pave the way for more personalised treatment.
Magazines and Educational Guides
Free download: This guide is intended to help you understand how cancers can develop in the body and what forms they can take, as well as taking you through the medical processes of diagnosis and treatment.
Free download: This guide gives you a broader and deeper understanding than the previous edition, to help you understand what considerations you need to make when designing a computational genomics workflow or platform.
Free download: This guide is designed to introduce you to how genomics is being integrated into the clinic, what goes into using a patient’s DNA to reach a diagnosis, and how this information can be communicated to primary care physicians.
The Genome Spot / Webinars
To fully benefit from the vast quantities of data from TCGA, tools for easy data visualisation and analysis must be developed for use of the non-computational scientist. Our panel of experts discuss TCGA data and the tools needed to make sense of it.
Comparison of Single Nucleotide Variants in Sequencing Data Produced by Illumina and Oxford Nanopore Technologies.
Come hear from David Grieg, Bioinformatician at Public Health England to learn more about the application of the MinION for the surveillance of Shiga toxin-producing Escherichia coli O157:H7.
Our panel of experts come together to discuss the benefits and drawbacks on the use of saliva DNA in genetic studies and how it’s currently being used to diminish biases in our databases and uncovering the role of epigenetics in psychiatric disorders.
The Mayo Clinic’s David Smith, talks about science fiction writer, Nancy Kress, whom he thinks is not only a great storyteller, but is also a genius in how she demonstrates how genetics can alter society within her novels.
There is a disconnect between scientists and the public when it comes to genomics. What is the public’s understanding of genomics and why is this important?
Following on from our feature last week, that discussed the ‘origin of life’, we sat down with George Church, a project supporter, to find hear his thoughts.
The Code, Part 3: It’s now easier than ever to peer into your own genetic code. But are all of the new companies out there offering you information about yourself that you can believe?
The Code, Part 2: Does the ability to more easily change the blueprint of life mean we’re on the path to repairing the broken bits in our genetic inheritance? Or have we tried this before and failed?
The Code, Part 1: The race to sequence the human genome was also billed as a race to end disease. So what happened?
The Short Read
Kat Arney is one of the “Top 10 Brits who make science sexy”, according to BBC America. Need we say more?
“How Can We Anticipate and Respond to Technologies and Information That is Rapidly Changing?” – Josephine Johnston
Josephine Johnston is an expert on the ethical, legal and policy implications of biomedical technologies, particularly as used in human reproduction, psychiatry, genetics, and neuroscience.
“I Would Like to See Widespread Reimbursement of Clinical Genomic Testing as Well as Screening” – Gavin Stone
Gavin Stone is an electronics engineer who joined Edico Genome in 2013 to lead corporate development and marketing for the DRAGEN™ Bio-IT Processor, the world’s first next-generation sequencing bioinformatics chip to massively speed up genomic medicine.
Around the Web
Repositive, has successfully concluded the pilot phase of its data-sharing platform for PDX cancer models and is now extending the scope of the platform to include a wider range of translational cancer models.
Karius has developed a next-generation sequencing test for microbial cell-free DNA that provides clinicians with a comprehensive test capable of identifying more than 1,250 pathogens directly from blood.
Cofactor Genomics, the developer of advanced RNA analysis tools, has announced that it has entered into an agreement with the National Cancer Institute, to demonstrate the clinical utility of its immune-profiling assay, Cofactor Paragon.
Worth reading this week: human cloning, ninja polymers fighting off superbugs, and genetics research failing most of the world’s population.
Some are exciting (Bill Gates on gene editing and George Church on how to live forever), some are informative (lab mice might be too clean, questioning drug pricing and freeing health data). You can read one, or you can read all five. That’s up to you!
Introducing our new webinar series, The Genome Spot. Each month we’ll be picking the brains of some of the leading researchers, to uncover some of the key movements, challenges and solutions in the field.